Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uday Popat

Showing results (71-80 of 262) with videos related to

Pageof 27
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|February 15, 2025
Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic LeukemiaNatalie Rafaeli, David Marin Costa, Celina Ledesma, et al.
American Journal of Hematology|September 28, 2011
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantationRichard W Joseph, Amin Alousi, Bhavana Konda, et al.
Haematologica|May 14, 2026
Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantationCharan Thej Reddy Vegivinti, Guillermo Montalban-Bravo, Kelly Chien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic SyndromesHans C Lee, Rima M Saliba, Gabriela Rondon, et al.
Blood|October 9, 2004
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosisMingjiang Xu, Edward Bruno, Joseph Chao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantationJonas A de Souza, Rima M Saliba, Poliana Patah, et al.
Bone Marrow Transplantation|December 12, 2018
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDSGheath Alatrash, Kelly M Kidwell, Peter F Thall, et al.
Leukemia & Lymphoma|October 26, 2011
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplantQaiser Bashir, Mark F Munsell, Sergio Giralt, et al.
Leukemia & Lymphoma|January 17, 2012
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplantAmer M Beitinjaneh, Rima Saliba, Qaiser Bashir, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantationBetul Oran, Piyanuch Kongtim, Uday Popat, et al.
Pageof 27

Showing results (71-80 of 262) with videos related to

Sort By:
Pageof 27
Clinical Lymphoma, Myeloma & Leukemia|February 15, 2025
Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic LeukemiaNatalie Rafaeli, David Marin Costa, Celina Ledesma, et al.
American Journal of Hematology|September 28, 2011
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantationRichard W Joseph, Amin Alousi, Bhavana Konda, et al.
Haematologica|May 14, 2026
Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantationCharan Thej Reddy Vegivinti, Guillermo Montalban-Bravo, Kelly Chien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic SyndromesHans C Lee, Rima M Saliba, Gabriela Rondon, et al.
Blood|October 9, 2004
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosisMingjiang Xu, Edward Bruno, Joseph Chao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantationJonas A de Souza, Rima M Saliba, Poliana Patah, et al.
Bone Marrow Transplantation|December 12, 2018
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDSGheath Alatrash, Kelly M Kidwell, Peter F Thall, et al.
Leukemia & Lymphoma|October 26, 2011
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplantQaiser Bashir, Mark F Munsell, Sergio Giralt, et al.
Leukemia & Lymphoma|January 17, 2012
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplantAmer M Beitinjaneh, Rima Saliba, Qaiser Bashir, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantationBetul Oran, Piyanuch Kongtim, Uday Popat, et al.
Pageof 27